Compare BGB & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BGB | BVS |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 527.0M | 482.9M |
| IPO Year | N/A | 2016 |
| Metric | BGB | BVS |
|---|---|---|
| Price | $11.34 | $8.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.25 |
| AVG Volume (30 Days) | 175.4K | ★ 311.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 9.75% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.42 |
| Revenue Next Year | N/A | $6.46 |
| P/E Ratio | ★ N/A | $26.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.47 | $5.81 |
| 52 Week High | $12.65 | $10.13 |
| Indicator | BGB | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 47.79 | 57.18 |
| Support Level | $10.98 | $6.42 |
| Resistance Level | $11.99 | $9.01 |
| Average True Range (ATR) | 0.11 | 0.40 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 72.82 | 52.52 |
Blackstone Strategic Credit Fund is a closed-end term fund. Its primary investment objective is to seek high current income. The secondary objective of the fund is to seek the preservation of capital. Under normal market conditions, the Fund invests at least 80% of its Managed Assets in senior, secured floating-rate loans. The fund also invest in second-lien loans and high yield bonds and employs financial leverage, which may increase risk to the Fund. The Fund has a limited term and absent shareholder approval to extend the life of the Fund.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.